Variant: rs13387042 

    present in Gene: LOC105373874;LOC101928278
    present in Chromosome: 2
    Position on Chromosome: 217041109
    Alleles of this Variant: A/G

rs13387042 in LOC105373874;LOC101928278 gene and Breast Carcinoma PMID 25751625 2015 Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.

PMID 21263130 2011 Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.

PMID 19330030 2009 A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

PMID 20453838 2010 Genome-wide association study identifies five new breast cancer susceptibility loci.

PMID 23535729 2013 Large-scale genotyping identifies 41 new loci associated with breast cancer risk.

PMID 17529974 2007 At present, no genes have been identified in the linkage disequilibrium block containing rs13387042. rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associated protein whose expression is implicated in breast cancer metastasis to bone.

rs13387042 in LOC105373874;LOC101928278 gene and Malignant neoplasm of breast PMID 23535729 2013 Large-scale genotyping identifies 41 new loci associated with breast cancer risk.

PMID 20453838 2010 Genome-wide association study identifies five new breast cancer susceptibility loci.

PMID 21263130 2011 Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.

PMID 19330030 2009 A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

PMID 17529974 2007 At present, no genes have been identified in the linkage disequilibrium block containing rs13387042. rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associated protein whose expression is implicated in breast cancer metastasis to bone.

rs13387042 in LOC105373874;LOC101928278 gene and Nasopharyngeal carcinoma PMID 20512145 2010 A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.